Victoria Miller, NP
Family · Springfield, ORNPI 1841733706
Payments from drug & device makers
Across 70 payments — averaging $21.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$207
- Pfizer$172
- AbbVie$166
- Boehringer Ingelheim$125
- GSK$119
- Hologic Sales And Service, LLC$97
- plus $588 from 18 others
What the payments were for
- Food & beverage$1,475100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 10 | $207 |
| Pfizer | 11 | $172 |
| AbbVie | 6 | $166 |
| Boehringer Ingelheim | 5 | $125 |
| GSK | 5 | $119 |
| Hologic Sales And Service, LLC | 4 | $97 |
| Exact Sciences | 4 | $88 |
| Novo Nordisk | 5 | $79 |
| Merck | 2 | $64 |
| Edwards Lifesciences | 2 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| AstraZeneca | 2 | $31 |
| Aimmune Therapeutics, Inc. | 1 | $23 |
| Madrigal Pharmaceuticals | 1 | $23 |
| Novartis | 1 | $21 |
| Ascendis Pharma Endocrinology Inc | 1 | $21 |
| Sanofi Pasteur Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $20 |
| Bayer | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Insulet Corporation | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Recordati_rare_diseases_inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $13 |
How this compares
$1,475 in reported general payments places this provider in the 90th percentile of 1,130 family providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 37 | $3,168 |
| Bupropion XlBupropion Hcl | 18 | $574 |
| Rosuvastatin Calcium | 13 | $266 |
| Gabapentin | 24 | $241 |
| Losartan Potassium | 21 | $228 |
| Escitalopram Oxalate | 12 | $221 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 16 | $219 |
| Buspirone Hcl | 11 | $216 |
| Trazodone Hcl | 27 | $216 |
| Atorvastatin Calcium | 32 | $206 |
| Levothyroxine Sodium | 40 | $199 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $186 |
| Lamotrigine | 15 | $178 |
| Metformin Hcl ErMetformin Hcl | 14 | $173 |
| Amlodipine Besylate | 19 | $121 |
Paid to pharmacies, not to this prescriber.
Other family in Springfield
- Rachel PangilinanPortland$103K
- Jodeanna SweeneyCentral Point$45K
- Lani DoserPortland$45K
- David ArnopoleMedford$38K
- Heather HermanCorvallis$34K
- Amy BartramOregon City$33K
- Leah GaedekePortland$26K
- Bobbi Lee RothTualatin$23K
- Susan ToftePortland$21K
- Leah WessenbergPortland$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.